Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting Aranesp®.
Aranesp® has not been proven to improve quality of life, fatigue, or well-being.
Aranesp® should not be used for the treatment of anemia:
The first step is talking with your healthcare provider about anemia before you receive chemotherapy. Also, you can keep track of your hemoglobin levels and let your healthcare provider know how you’re feeling.
If you are seeking general knowledge, support, research updates, or more information on cancer and chemotherapy, try visiting one of the following websites:
A website dedicated to helping patients prepare for treatment with chemotherapy, managing its side effects, and life after chemotherapy.
A website for the Lung Cancer Alliance, a nonprofit organization dedicated to fighting lung cancer in the US, with educational and support resources.
The above list of third-party resources is for your information only. Unless otherwise specified, Amgen does not endorse and is not responsible for the content included in these resources.
Aranesp® may cause serious side effects that can lead to death, including:
If you decide to take Aranesp®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take Aranesp®, even if you do not have an increase in your hemoglobin level.
Before taking Aranesp®, tell your doctor if you: have heart disease; have high blood pressure; have had a seizure or stroke; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
If you know you are allergic to latex, talk to your healthcare provider before using Aranesp® because the needle cover on the prefilled syringe contains latex.
These are not all the possible side effects of ARANESP®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting Aranesp®.
Aranesp® has not been proven to improve quality of life, fatigue, or well-being.
Aranesp® should not be used for the treatment of anemia:
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide.
See More +
Aranesp® may cause serious side effects that can lead to death, including:
If you decide to take Aranesp®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take Aranesp®, even if you do not have an increase in your hemoglobin level.
Before taking Aranesp®, tell your doctor if you: have heart disease; have high blood pressure; have had a seizure or stroke; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
If you know you are allergic to latex, talk to your healthcare provider before using Aranesp® because the needle cover on the prefilled syringe contains latex.
These are not all the possible side effects of ARANESP®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting Aranesp®.
Aranesp® has not been proven to improve quality of life, fatigue, or well-being.
Aranesp® should not be used for the treatment of anemia:
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide.